Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00257491
Status:
COMPLETED
Last Update Posted:
2013-11-11
First Post:
2005-11-22
Brief Title:
Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mgHydrochlorothiazide 125 mg Micardis Plus by Ambulatory Blood Pressure Monitoring ABPM in Patients With Mild to Moderate Essential Hypertension
Sponsor:
Organization:
Boehringer Ingelheim
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
29
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: